NextCure, Inc. (NXTC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 40.33M |
| Enterprise Value | 19.51M |
| P/E Ratio | -0.51 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.34 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.33 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.89 |
| Return On Equity | -1.75 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.19M |
| EBITDA | -53.66M |
| Net Income | -55.84M |
| Diluted EPS | -19.65 |
Balance Sheet
| Total Cash | 20.09M |
| Total Cash/Share | 3.78 |
| Total Debt | 4.29M |
| Total Debt/Equity | 0.35 |
| Current Ratio | 3.47 |
| Book Value Per Share | 2.29 |
Price History
| 52-Week Change | -40.64 |
| 52-Week High | 15.74 |
| 52-Week Low | 1.55 |
| Moving Average 50 Days | 6.34 |
| Moving Average 200 Days | 8.12 |
Statistics
| Average Volume | 194,429 |
| Shares Outstanding | 4.58M |
| % Held by Institutions | 32.68 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | July 14, 2025 |
AD
